Menopausal implications of polycystic ovarian syndrome

Rashmi Kudesia, Genevieve S. Neal-Perry

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Polycystic ovary syndrome (PCOS) is a common endocrinopathy affecting up to 8 to 10% of reproductive-aged women. Although the medical and metabolic consequences of PCOS are well-described in young reproductive-aged women, its impact on female reproductive senescence and the menopausal transition is poorly understood. This review summarizes current knowledge regarding the effect of PCOS is menopausal and perimenopausal women. We also highlight areas that are ripe for clinical research.

Original languageEnglish (US)
Pages (from-to)222-229
Number of pages8
JournalSeminars in Reproductive Medicine
Issue number3
StatePublished - Jan 1 2014


  • PCOS
  • hormone therapy
  • menopause

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Reproductive Medicine
  • Endocrinology
  • Obstetrics and Gynecology
  • Physiology (medical)


Dive into the research topics of 'Menopausal implications of polycystic ovarian syndrome'. Together they form a unique fingerprint.

Cite this